US EditionBayer Files Patent Lawsuits Against Pfizer, Moderna, BioNTech, and J&J Over mRNA Technology
Bayer alleges Pfizer, BioNTech, Moderna, and Johnson & Johnson copied mRNA stabilization technology from Monsanto patents dating to the 1980s; Pfizer and BioNTech earned $3.3 billion in 2024.
- On Tuesday, Bayer's Monsanto unit filed federal lawsuits in Delaware against Pfizer, BioNTech and Moderna and in New Jersey against Johnson & Johnson, seeking unspecified monetary damages but not blocking vaccine production.
- Dating to the 1980s, Monsanto scientists developed mRNA technology to reduce instability in crops, and Bayer alleges Pfizer, BioNTech, and Moderna used it in their COVID-19 vaccines.
- A Moderna spokesperson said it would defend itself, while Pfizer and BioNTech earned US$3.3 billion from Comirnaty and Moderna earned US$3.2 billion from Spikevax in 2024.
- The filings join existing litigation, adding to patent disputes including the Moderna v. Pfizer 2022 lawsuit; spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond, and Bayer was not involved in vaccine development.
- Corporate context: Bayer's 2018 purchase of Monsanto for US$66 billion included taking control of its patents, and Bayer moved to drop the Monsanto brand shortly around the acquisition.
19 Articles
19 Articles
Bayer, a pharmaceutical company, has sued the Corona vaccine manufacturers Pfizer, BioNTech and Moderna, alleging that they had infringed patents with their mRNA vaccines.
German giant Bayer pursues legal battle around messenger RNA technology used by Pfizer, Moderna, BioNTech and Johnson & Johnson laboratories to manufacture vaccines
Bayer sues COVID vaccine makers over mRNA technology
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a Bayer spokesperson confirmed.
The Bayer Group is suing the Corona vaccine manufacturers Pfizer, Biontech and Moderna in the USA and accusing them of violating patents.
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
